SCHEMBL6670976

SCHEMBL6670976

CC(=O)C(=O)Oc1ccc(C#N)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.53
ALDH1A1 P00352 1/20 0.53
MGLL Q99685 2/20 0.50
F2 P00734 1/20 0.47
MMP2 P08253 3/20 0.47
PARP15 Q460N3 1/20 0.47
PARP10 Q53GL7 1/20 0.47
PARP2 Q9UGN5 1/20 0.47
POLB P06746 2/20 0.46
RAB9A P51151 2/20 0.46
KDM4E B2RXH2 1/20 0.46
MEN1 O00255 1/20 0.46
LMNA P02545 1/20 0.46
PKM P14618 1/20 0.46
MAPK1 P28482 1/20 0.46
KMT2A Q03164 1/20 0.46
IL18 Q14116 1/20 0.46
MMP3 P08254 2/20 0.45
MMP1 P03956 1/20 0.44
MMP9 P14780 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14367097 0.88 PARP15 (0.53) MAPTALDH1A1MGLLF2MMP2
SCHEMBL447166 0.85 ELANE (0.54) MAPTALDH1A1MGLLF2MMP2
SCHEMBL14367088 0.85 MAPT (0.50) MAPTALDH1A1MGLLF2MMP2
SCHEMBL337646 0.84 LMNA (0.57) MAPTALDH1A1MGLLF2MMP2
SCHEMBL17325947 0.82 F2 (0.49) MAPTALDH1A1MGLLF2MMP2
SCHEMBL30763517 0.81 MMP2 (0.50) MAPTALDH1A1MGLLMMP2KDM4E
SCHEMBL4878038 0.79 MAPT (0.50) MAPTALDH1A1MGLLF2MMP2
SCHEMBL1355778 0.79 PARP15 (0.53) MAPTALDH1A1MGLLF2MMP2
SCHEMBL5945230 0.79 HSD17B10 (0.58) MAPTALDH1A1MGLLMMP2POLB
SCHEMBL10065739 0.79 MGLL (0.46) MAPTALDH1A1MGLLF2MMP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7288360-B2 Image recording material FUJIFILM CORPORATION (JP) 2007-10-30 US disclosed
US-7288360-B2 Image recording material FUJIFILM CORPORATION (JP) 2007-10-30 US disclosed
EP-1038953-B1 Stereoselective transaminase, gene encoding said protein and use thereof SUMITOMO CHEMICAL CO (JP) 2004-09-22 EP disclosed
US-6727083-B2 PROTEIN FOR USE IN THE GENERATION OF BRONCHODILATING AGENT, PESTICIDES, FUNGICIDE, HERBICIDES AND FOR USE IN THE TREATMENT OF DIABETES SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2004-04-27 US disclosed
US-20020127664-A1 Protein capable of catalyzing transamination stereoselectively, gene encoding said protein and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED 2002-09-12 US disclosed
US-6413752-B1 AMINO ACID SEQUENCE OF ENZYME WHICH CONVERTS ACETOPHENONE TO OPTICALLY ACTIVE 1-PHENYLETHYLAMINE IN PRESENCE OF RACEMIC SEC-BUTYLAMINE SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2002-07-02 US disclosed
EP-1038953-A1 Stereoselective transaminase, gene encoding said protein and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2000-09-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020127664-A1 Protein capable of catalyzing transamination stereoselectively, gene encoding said protein and use thereof THEM6, FARSB, FARSA MAPT 4403/4885ALDH1A1 2092/4885MGLL 2337/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.